In a stunning verdict that reverberated through the corridors of the medical device industry, Laura Perryman, the ex-CEO of Stimwave, was found guilty on Wednesday by a New York federal jury. The charges? Healthcare fraud and conspiracy to commit health care fraud and wire fraud. The trial, akin to a high-stakes legal drama, unfolded over three intense days, with a jury of twelve delivering their verdict after deliberating for approximately 12 hours.
The Deceptive Scheme Unveiled
At the heart of the case lay the insidious scheme orchestrated by Perryman, alleged prosecutors. The crux of their argument was the fabrication and sale of the StimQ PNS System, a neurostimulation device purportedly designed to alleviate chronic pain. However, concealed within this innovative technology was a sinister element – a counterfeit component, devoid of any functionality, strategically integrated to inflate billings and defraud Medicare and private insurers.
Ex-Stimwave CEO Found Guilty Of Healthcare Fraud : The Fallout and Legal Battles
The ramifications of Perryman’s deceit were profound and far-reaching. Not only did her actions deceive patients and medical professionals, but they also wreaked havoc on investors. The U.S. Securities and Exchange Commission, in a separate legal battle, accused Perryman of swindling investors out of a staggering $41 million.
